Ophthalmologic assessment and intracranial pressure in children: diagnostic methods, clinical correlations, and future directions - Takeaways - MDSpire

Ophthalmologic assessment and intracranial pressure in children: diagnostic methods, clinical correlations, and future directions

  • By

  • Elena Hernández-García

  • Barbara Burgos-Blasco

  • Noemi Güemes-Villahoz

  • Laura Morales-Fernandez

  • Jose Ignacio Fernandez-Vigo

  • Enrique Santos-Bueso

  • Rosario Gomez-de-Liaño

  • Julian García-Feijóo

  • May 7, 2026

  • 0 min

Share

  • 1

    Increased intracranial pressure (ICP) in children can lead to severe neurological complications, including brain herniation and vision loss.

  • 2

    Diagnosis of elevated ICP in pediatric patients is challenging due to subtle and non-specific symptoms that overlap with common disorders.

  • 3

    Ophthalmologic evaluation, particularly fundoscopic examination, is crucial for early detection of increased ICP in children.

  • 4

    Normal values for ICP and ocular anatomy vary with age, complicating the interpretation of ophthalmologic findings in children.

  • 5

    The review highlights the need for integrated diagnostic approaches and further research to improve early recognition of elevated ICP.

Original Source(s)

Ophthalmologic assessment and intracranial pressure in children: diagnostic methods, clinical correlations, and future directions

  • by Elena Hernández-García, Barbara Burgos-Blasco, Noemi Güemes-Villahoz, Laura Morales-Fernandez, Jose Ignacio Fernandez-Vigo, Enrique Santos-Bueso, Rosario Gomez-de-Liaño, Julian García-Feijóo

  • May 7, 2026

Related Content

Myopia Severity Tied to Pediatric Retinal Pathology

Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Gene Therapy Reaches XLRS Milestone

Atsena Therapeutics reports positive interim data for XLRS gene therapy

  • May 25, 2026

  • 3 min